Melanie Kelly

Melanie Kelly

Company: Tetra Bio-Pharma

Job title: Chief Scientific Officer


Challenges & Successes in Moving Promising Preclinical Cannabinoid Drug Candidates to the Clinic 1:00 pm

Identify robust pre-clinical drug targets for cannabinoid drug development Evaluate pre- and post-COVID cannabinoid drug development challenges: spotlight on systemic inflammatory disease Examine future development of cannabinoid drug products for expanded disease indicationsRead more

day: Day One Track A - afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.